Human stem cells used to cure renal anemia in mice

September 28, 2017 by Bob Yirka report
Microscopic images of stem-cell derived EPO-producing cells that were used to treat renal anemia in mice. Credit: H. Hitomi et al., Science Translational Medicine (2017)

(Medical Xpress)—A team of researchers with Kyoto University and Kagawa University, both in Japan, has cured renal anemia in mice by injecting them with treated human stem cells. In their paper published in Science Translational Medicine, the group describes their approach and how well it worked.

Chronic kidney disease is a serious ailment resulting in a host of symptoms due to the body's reduced ability to process waste and fluids—many patients eventually experience , which requires them to undergo routine dialysis or a kidney transplant. Less well known is that people with also suffer from renal anemia because the kidneys manufacture the hormone erythropoietin (EPO), which causes the body to produce without which the blood cannot carry enough oxygen to the brain and other body parts. The current treatment for renal anemia is injections of EPO every few days, which, for many people, is impractical because of the cost and side effects. In this new effort, the researchers have found a possible new treatment—injecting treated directly into the kidneys.

In their experiments, the researchers collected stem cells from human cord blood (from the umbilical cord) and then treated them with growth factors that changed them to that grew into mature cells capable of producing EPO. The team then injected the treated cells into the kidneys of mice suffering from renal anemia and monitored them for the rest of their lives.

Progressively zoomed-in images of stem-cell derived EPO-producing cells and mouse liver for comparison (bottom right), showing secretory structures called vesicles (indicated by arrows). Credit: H. Hitomi et al., Science Translational Medicine (2017)

The team reports that for all of the mice tested, EPO levels were approximately 20 times higher than for control mice after just four weeks—putting them in the normal range. They report also that the levels were maintained through the life of the mice, which, the team notes, means they were cured of the ailment.

It is not clear yet, of course, whether the procedure would work with human patients, but the group intends to continue their research with the goal of finding out. If the procedure works as intended and does not cause harmful side effects, people in the future suffering from kidney disease may no longer have to worry about also dealing with anemia.

Human stem cells used to cure renal anemia in mice
Images of blood cells forming in response to purified EPO protein from conventional sources (left) and from stem-cell derived EPO producing cells (left). Credit: H. Hitomi et al., Science Translational Medicine (2017)

Explore further: Fixing common blood disorder would make kidney transplants more successful

More information: Hirofumi Hitomi et al. Human pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in mice, Science Translational Medicine (2017). DOI: 10.1126/scitranslmed.aaj2300

Abstract
The production of erythropoietin (EPO) by the kidneys, a principal hormone for the hematopoietic system, is reduced in patients with chronic kidney disease (CKD), eventually resulting in severe anemia. Although recombinant human EPO treatment improves anemia in patients with CKD, returning to full red blood cell production without fluctuations does not always occur. We established a method to generate EPO-producing cells from human induced pluripotent stem cells (hiPSCs) by modifying previously reported hepatic differentiation protocols. These cells showed increased EPO expression and secretion in response to low oxygen conditions, prolyl hydroxylase domain–containing enzyme inhibitors, and insulin-like growth factor 1. The EPO protein secreted from hiPSC-derived EPO-producing (hiPSC-EPO) cells induced the erythropoietic differentiation of human umbilical cord blood progenitor cells in vitro. Furthermore, transplantation of hiPSC-EPO cells into mice with CKD induced by adenine treatment improved renal anemia. Thus, hiPSC-EPO cells may be a useful tool for clarifying the mechanisms of EPO production and may be useful as a therapeutic strategy for treating renal anemia.

Related Stories

Fixing common blood disorder would make kidney transplants more successful

December 22, 2011
Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). ...

Green mamba peptide found to reduce symptoms of kidney disease in mice

June 20, 2017
(Medical Xpress)—A team of researchers from France, Germany and Belgium has found that giving a peptide found in green mamba venom to mice with a kidney disease led to reduced symptoms. In their paper published in Proceedings ...

Induced pluripotent stem cells show promise for kidney treatment

July 21, 2015
One promising way to treat diseased or damaged kidneys is cell therapies that include the transplantation of renal progenitor cells, which can then develop into the cells needed for full recovery. Acquiring a sufficient number ...

Common virus may cause anemia in patients with kidney disease

April 10, 2014
A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology ...

Stem cell-derived kidneys connect to blood vessels when transplanted into mice

November 19, 2015
Various research groups are collecting different types of cells and turning them into induced pluripotent stem (iPS) cells that can then generate diverse types of cells and tissues in the body. Now investigators have transplanted ...

Recommended for you

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

Large variety of microbial communities found to live along female reproductive tract

October 18, 2017
(Medical Xpress)—A large team of researchers from China (and one each from Norway and Denmark) has found that the female reproductive tract is host to a far richer microbial community than has been thought. In their paper ...

Study of what makes cells resistant to radiation could improve cancer treatments

October 18, 2017
A Johns Hopkins University biologist is part of a research team that has demonstrated a way to size up a cell's resistance to radiation, a step that could eventually help improve cancer treatments.

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.